BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7635520)

  • 1. Functional analysis of the effects of a fully humanized anti-CD4 antibody on resting and activated human T cells.
    Bartholomew M; Brett S; Barber K; Rossman C; Crowe S; Tite J
    Immunology; 1995 May; 85(1):41-8. PubMed ID: 7635520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of specific surface receptors and activation sensitization in primary resting CD4+ T lymphocytes by the Nef protein of HIV-1.
    Keppler OT; Tibroni N; Venzke S; Rauch S; Fackler OT
    J Leukoc Biol; 2006 Mar; 79(3):616-27. PubMed ID: 16365153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential functional effects of a humanized anti-CD4 antibody on resting and activated human T cells.
    Brett SJ; Rowan W; Smith M; Bartholomew M; Tite JP
    Immunology; 1997 Jul; 91(3):346-53. PubMed ID: 9301522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nef 27, but not the Nef 25 isoform of human immunodeficiency virus-type 1 pNL4.3 down-regulates surface CD4 and IL-2R expression in peripheral blood mononuclear cells and transformed T cells.
    Greenway AL; McPhee DA; Grgacic E; Hewish D; Lucantoni A; Macreadie I; Azad A
    Virology; 1994 Jan; 198(1):245-56. PubMed ID: 7903128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superantigen-driven, CD8+ T cell-mediated down-regulation: CD95 (Fas)-dependent down-regulation of human Ig responses despite CD95-independent killing of activated B cells.
    Stohl W; Lynch DH; Starling GC; Kiener PA
    J Immunol; 1998 Oct; 161(7):3292-8. PubMed ID: 9759844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of MHC-unrestricted cytolytic CD4+ T cells against virally infected target cells by cross-linking CD4 molecules.
    Choi SH; Splitter GA
    J Immunol; 1994 Nov; 153(9):3874-81. PubMed ID: 7930600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological activities on T lymphocytes of a baculovirus-expressed chimeric recombinant IgG1 antibody with specificity for the CDR3-like loop on the D1 domain of the CD4 molecule.
    Troadec S; Bès C; Chentouf M; Nguyen B; Briant L; Jacquet C; Chebli K; Pugnière M; Roquet F; Cerutti M; Chardès T
    Clin Immunol; 2006 Apr; 119(1):38-50. PubMed ID: 16426893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of human T cell response to staphylococcal enterotoxin B by prior ligation of surface CD4 molecules.
    Fournel S; Morel P; Revillard JP; Lizard G; Bonnefoy-Berard N
    Cell Immunol; 1993 Aug; 150(1):194-204. PubMed ID: 8102087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reverse signalling of membrane-integrated tumour necrosis factor differentially regulates alloresponses of CD4+ and CD8+ T cells against human microvascular endothelial cells.
    Vudattu NK; Holler E; Ewing P; Schulz U; Haffner S; Burger V; Kirchner S; Andreesen R; Eissner G
    Immunology; 2005 Aug; 115(4):536-43. PubMed ID: 16011522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
    Woods M; Guy R; Waldmann H; Glennie M; Alexander DR
    Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD95 (Fas)-based, superantigen-dependent, CD4+ T cell-mediated down-regulation of human in vitro immunoglobulin responses.
    Stohl W; Elliott JE; Lynch DH; Kiener PA
    J Immunol; 1998 Jun; 160(11):5231-8. PubMed ID: 9605118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation.
    de Waal Malefyt R; Yssel H; de Vries JE
    J Immunol; 1993 Jun; 150(11):4754-65. PubMed ID: 7684412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of human B cell responsiveness by CD4+ T cells does not involve CD95-CD95 ligand interactions.
    Hirohata S
    Cell Immunol; 1997 Nov; 181(2):182-91. PubMed ID: 9398405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of CD4-mediated down-regulation of T cell adhesion to B cells by flow cytometry and fluorescence microscopy.
    Hauss P; Selz F; Fischer A
    Cytometry; 1996 Jan; 23(1):39-47. PubMed ID: 14650439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro antitumoral activity of baculovirus-expressed chimeric recombinant anti-CD4 antibody 13B8.2 on T-cell lymphomas.
    Troadec S; Chentouf M; Cérutti M; Nguyen B; Olive D; Bès C; Chardès T
    J Immunother; 2007; 30(2):190-202. PubMed ID: 17471166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.
    Woo EY; Chu CS; Goletz TJ; Schlienger K; Yeh H; Coukos G; Rubin SC; Kaiser LR; June CH
    Cancer Res; 2001 Jun; 61(12):4766-72. PubMed ID: 11406550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies recognizing CD24 LAP epitope on human T cells enhance CD28 and IL-2 T cell proliferation.
    Salamone MC; Rosselot C; Salamone GV; Barboza M; Kado M; Fainboim L
    J Leukoc Biol; 2001 Feb; 69(2):215-23. PubMed ID: 11272271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody-induced CD3-CD4 coligation inhibits TCR/CD3 activation in the absence of costimulatory signals in normal mouse CD4(+) T lymphocytes.
    Portolés P; de Ojeda G; Criado G; Fernández-Centeno E; Rojo JM
    Cell Immunol; 1999 Aug; 195(2):96-109. PubMed ID: 10448009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 down-regulates CD4 costimulation of TCR/CD3-directed tyrosine phosphorylation through CD4/p56lck dissociation.
    Kanner SB; Haffar OK
    J Immunol; 1995 Mar; 154(6):2996-3005. PubMed ID: 7876562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligation of cell surface CD4 inhibits activation-induced death of human T lymphocytes at the level of Fas ligand expression.
    Oberg HH; Sanzenbacher R; Lengl-Janssen B; Dobmeyer T; Flindt S; Janssen O; Kabelitz D
    J Immunol; 1997 Dec; 159(11):5742-9. PubMed ID: 9548519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.